DEAPRIL-ST Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Deapril-st, and when can generic versions of Deapril-st launch?
Deapril-st is a drug marketed by Bristol Myers Squibb and is included in one NDA.
The generic ingredient in DEAPRIL-ST is ergoloid mesylates. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergoloid mesylates profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEAPRIL-ST?
- What are the global sales for DEAPRIL-ST?
- What is Average Wholesale Price for DEAPRIL-ST?
Summary for DEAPRIL-ST
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| DailyMed Link: | DEAPRIL-ST at DailyMed |
US Patents and Regulatory Information for DEAPRIL-ST
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | DEAPRIL-ST | ergoloid mesylates | TABLET;SUBLINGUAL | 085020-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
